Estimates were made for 19 countries and territories in the IDF South and Central America (SACA) Region. Estimates for diabetes prevalence in adults aged 20-79 years were taken from 27 data sources from 16 countries. Only Brazil and Chile had studies completed within the past five years.
IDF projects that the number of people with diabetes in SACA Region will increase 48% reaching 49 million by 2045 and the prevalence of diabetes will increase 25% reaching 11.9% in 2045. In 2021, 65.3 billion USD was spent on diabetes in SACA Region, representing 6.7% of the total spent worldwide.
| At a glance | 2000 | 2011 | 2021 | 2030 | 2045 |
|---|---|---|---|---|---|
| Diabetes estimates (20-79 y) | |||||
| People with diabetes, in 1,000s | 8,553.3 | 25,121.5 | 32,497.1 | 40,000.0 | 49,000.0 |
| Age-adjusted comparative prevalence of diabetes, % | 3.7 | 9.2 | 8.2 | 9.2 | 9.9 |
| People with undiagnosed diabetes, in 1,000s | - | - | 10,671.5 | - | - |
| Proportion of people with undiagnosed diabetes, % | - | - | 32.8 | - | - |
| Impaired glucose tolerance (IGT) estimates (20-79 y) | |||||
| People with IGT, in 1,000s | - | 15,100.0 | 39,624.6 | 45,700.0 | 52,700.0 |
| Age-adjusted comparative prevalence of IGT, % | - | 5.4 | 10.9 | 11.5 | 11.7 |
| Impaired fasting glucose (IFG) estimates (20-79 y) | |||||
| People with IFG, in 1,000s | - | - | 47,005.4 | 54,300.0 | 62,800.0 |
| Age-adjusted comparative prevalence of IFG, % | - | - | 10.0 | 10.8 | 10.9 |
| Mortality attributable to diabetes (20-79 y) | |||||
| Deaths attributable to diabetes | - | 227,200.0 | 410,206.0 | 0.0 | - |
| Proportion of diabetes-related deaths in people under 60 y, % | - | - | - | - | - |
| Type 1 diabetes estimates in children and adolescents | |||||
| New cases of type 1 diabetes (0-14 y), in 1,000s | 7.6 | 5.5 | 9.5 | - | - |
| New cases of type 1 diabetes (0-19 y), in 1,000s | - | - | 12.3 | - | - |
| Type 1 diabetes (0-14 y), in 1,000s | 36.0 | 36.1 | 64.6 | - | - |
| Type 1 diabetes (0-19 y), in 1,000s | - | - | 121.3 | - | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |||||
| Live births affected by HIP | - | - | 1,019,015.1 | - | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 15.8 | - | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 70,099.8 | - | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 120,741.6 | - | - |
| Diabetes-related health expenditure | |||||
| Total diabetes-related health expenditure, USD million | - | 20,800.0 | 65,281.0 | 80,200.0 | 87,800.0 |
| Total diabetes-related health expenditure, ID million | - | - | 122,736.6 | 160,778.3 | 181,179.4 |
| Diabetes-related health expenditure per person, USD | - | 932.8 | 2,190.4 | 2,678.4 | 2,447.9 |
| Diabetes-related health expenditure per person, ID | - | - | 4,118.2 | 7,497.7 | 7,394.9 |
| Demographics | |||||
| Total adult population (20-79 y), in 1,000s | 233,013.0 | 289,000.0 | 341,253.8 | 376,772.8 | 411,682.1 |
| Population of children (0-14 y), in 1,000s | 135,142.0 | - | 116,792.7 | - | - |
| Population of children and adolescents (0-19 y), in 1,000s | - | - | 156,962.8 | - | - |